Koninklijke DSM NV (Koninklijke DSM NV) EBIT per Share : $4.34 (TTM As of Dec. 2022)

View and export this data going back to . Start your Free Trial

What is Koninklijke DSM NV EBIT per Share?

Koninklijke DSM NV's EBIT per Share for the six months ended in Dec. 2022 was $2.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2022 was $4.34.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Koninklijke DSM NV's EBIT per Share or its related term are showing as below:

KDSKF's 3-Year EBIT Growth Rate is not ranked ^*
in the Chemicals industry.
Industry Median: 4.6
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Koninklijke DSM NV's EBIT for the six months ended in Dec. 2022 was $345 Mil.

Koninklijke DSM NV EBIT per Share Historical Data

The historical data trend for Koninklijke DSM NV's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Koninklijke DSM NV EBIT per Share Chart

Koninklijke DSM NV Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

8.12

5.60

4.89

4.66

4.43

Koninklijke DSM NV Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
EBIT per Share	Get a 7-Day Free Trial															2.11	2.74	2.09	2.34	2.00

Koninklijke DSM NV EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Koninklijke DSM NV's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	766.949	/	173.304
=	4.43

Koninklijke DSM NV's EBIT per Share for the quarter that ended in Dec. 2022 is calculated as

	EBIT per Share		(Q: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	345.339	/	173.054
=	2.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.34

Koninklijke DSM NV (OTCPK:KDSKF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Koninklijke DSM NV EBIT per Share Related Terms

Thank you for viewing the detailed overview of Koninklijke DSM NV's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Koninklijke DSM NV (Koninklijke DSM NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Koninklijke DSM NV (OTCPK:KDSKF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Het Overloon 1, P.O. Box 6500, Heerlen, LI, NLD, 6411 TE

Website

https://www.dsm.com

Koninklijke DSM NV is a global, purpose-led company in Health, Nutrition, and Bioscience, applying science to improve the health of people, animals, and the planet. The company delivers innovative business solutions for human and animal nutrition, personal care and aroma, medical devices, green products and applications, new mobility, and connectivity. The company's segment includes Animal Nutrition & Health (ANH), Health, Nutrition & Care (HNC), and Food & Beverage (F&B), where the majority of its revenue is generated from Animal Nutrition & Health (ANH).